Since the expression of PLCE1 and PRKCA was associated with clinicopathological characteristics, we then determined whether the expression of PLCE1 and PRKCA is linked to ESCC patient survival time. This evidence concerns the gene PRKCA and esophageal squamous cell carcinoma.